Приказ основних података о документу

dc.creatorDjuris, Jelena
dc.creatorMilovanovic, Stoja
dc.creatorMedarevic, Djordje
dc.creatorDobricic, Vladimir
dc.creatorDapčević, Aleksandra
dc.creatorIbric, Svetlana
dc.date.accessioned2022-03-11T09:38:25Z
dc.date.available2019-11-07
dc.date.issued2019
dc.identifier.issn0378-5173
dc.identifier.urihttp://TechnoRep.tmf.bg.ac.rs/handle/123456789/5030
dc.description.abstractSolid dispersions production is one of the substantial approaches for improvement of poor drug solubility. Additionally, supercritical fluid assisted method for preparation of solid dispersions can offer many advantages in comparison to the conventional melting or solvent-evaporation methods. Miscibility analysis provides valuable guidance for selection of the most appropriate polymeric carrier for dispersion of the drug of interest. In addition to the increased drug release rate, solid dispersions should have proper mechanical attributes in order to be successfully formulated in the final solid dosage form such as tablet. Therefore, several pharmaceutical grade polymers have been selected for development of BCS Class II drug carvedilol (CARV) solid dispersions. They were compared based on behavior in supercritical CO 2 and affinity towards CARV calculated from the miscibility analysis. By utilization of the supercritical CO 2 assisted method, solid dispersions of CARV with the selected (co)polymers (polyvinylpyrrolidone (PVP), hydroxypropyl methylcellulose (HPMC), Soluplus® and Eudragit®) were obtained. Properties of the prepared CARV-polymer dispersions were observed by the polarizing and scanning electron microscopy and analyzed by differential scanning calorimetry and Fourier transform infrared spectroscopy. CARV was additionally characterized by X-ray powder diffraction. Furthermore, in vitro dissolution studies and dynamic compaction analysis were performed on the selected samples of solid dispersions. Among the studied polymers, PVP and HPMC have been identified as polymers with the highest affinity towards CARV, based on the calculated δ p values. This has been also confirmed with the highest dissolution efficiency of CARV-PVP and CARV-HPMC solid dispersions. Solid state characterization indicated that CARV was dispersed either molecularly, or in the amorphous form, depending on interactions with each polymer. Determination of CARV-PVP and CARV-HPMC mechanical properties revealed that CARV-PVP solid dispersion has superior compactibility and tabletability. Therefore, CARV-PVP solid dispersion has been highlighted as the most appropriate for the further development of tablets as the final dosage form. Presented study provides an example for efficient approach for development of poorly soluble drug solid dispersion with satisfactory tableting properties.sr
dc.language.isoensr
dc.publisherElsevier B.V.sr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/45007/RS//sr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/45017/RS//sr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Technological Development (TD or TR)/34007/RS//sr
dc.relation.isversionofhttp://technorep.tmf.bg.ac.rs/handle/123456789/4335
dc.relation.isversionofhttp://dx.doi.org/10.1016/j.ijpharm.2018.11.015
dc.rightsembargoedAccesssr
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceInternational Journal of Pharmaceuticssr
dc.subjectCarvedilolsr
dc.subjectImproved dissolutionsr
dc.subjectSolid dispersionsr
dc.subjectSupercritical CO 2sr
dc.subjectTabletabilitysr
dc.titleSelection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersionssr
dc.typearticlesr
dc.rights.licenseBY-NC-NDsr
dc.citation.epage200
dc.citation.rankM21
dc.citation.spage190
dc.citation.volume554
dc.description.otherThis is the peer-reviewed version of the following article: Đuriš J, Milovanović S, Medarević Đ, Dobričić V, Dapčević A, Ibrić S. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions. in International Journal of Pharmaceutics. 2019;554:190-200. [https://doi.org/10.1016/j.ijpharm.2018.11.015]
dc.description.otherPublished version: [http://technorep.tmf.bg.ac.rs/handle/123456789/4335]
dc.identifier.doi10.1016/j.ijpharm.2018.11.015
dc.identifier.fulltexthttp://TechnoRep.tmf.bg.ac.rs/bitstream/id/7407/Selection_of_the_suitable_acc_2019.pdf
dc.identifier.scopus2-s2.0-85056454143
dc.identifier.wos000454421400019
dc.type.versionacceptedVersionsr


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу